These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 12784320
21. Aminophylline alters pharmacokinetics of carbamazepine but not that of sodium valproate--a single dose pharmacokinetic study in human volunteers. Kulkarni C, Vaz J, David J, Joseph T. Indian J Physiol Pharmacol; 1995 Apr; 39(2):122-6. PubMed ID: 7649598 [Abstract] [Full Text] [Related]
22. Effect of Piperine on the Metabolism and Pharmacokinetics of Carbamazepine in Healthy Volunteers. Bedada SK, Appani R, Boga PK. Drug Res (Stuttg); 2017 Jan; 67(1):46-51. PubMed ID: 27776366 [Abstract] [Full Text] [Related]
23. Therapeutic effects of ciprofloxacin on the pharmacokinetics of carbamazepine in healthy adult male volunteers. Shahzadi A, Javed I, Aslam B, Muhammad F, Asi MR, Ashraf MY, Zia-ur-Rahman. Pak J Pharm Sci; 2011 Jan; 24(1):63-8. PubMed ID: 21190921 [Abstract] [Full Text] [Related]
24. Influence of activated charcoal on the pharmacokinetics and the clinical features of carbamazepine poisoning. Brahmi N, Kouraichi N, Thabet H, Amamou M. Am J Emerg Med; 2006 Jul; 24(4):440-3. PubMed ID: 16787802 [Abstract] [Full Text] [Related]
25. Effect of probenecid on the pharmacokinetics of carbamazepine in healthy subjects. Kim KA, Oh SO, Park PW, Park JY. Eur J Clin Pharmacol; 2005 Jun; 61(4):275-80. PubMed ID: 15915352 [Abstract] [Full Text] [Related]
26. No pharmacokinetic interaction between lacosamide and carbamazepine in healthy volunteers. Cawello W, Nickel B, Eggert-Formella A. J Clin Pharmacol; 2010 Apr; 50(4):459-71. PubMed ID: 19841161 [Abstract] [Full Text] [Related]
27. Effect of lamotrigine on the pharmacokinetics of carbamazepine and its active metabolite in dogs. Matar KM, Nicholls PJ, Bawazir SA, Al-Khamis KI, Al-Hassan MI. Eur J Drug Metab Pharmacokinet; 2001 Apr; 26(3):149-53. PubMed ID: 11695714 [Abstract] [Full Text] [Related]
28. Steady state pharmacokinetics of carbamazepine-phenobarbital interaction in patients with epilepsy. Sennoune S, Iliadis A, Bonneton J, Barra Y, Genton P, Mesdjian E. Biopharm Drug Dispos; 1996 Mar; 17(2):155-64. PubMed ID: 8907722 [Abstract] [Full Text] [Related]
29. Effect of honey on carbamazepine kinetics in rabbits. Koumaravelou K, Adithan C, Shashindran CH, Asad M, Abraham BK. Indian J Exp Biol; 2002 May; 40(5):560-3. PubMed ID: 12622202 [Abstract] [Full Text] [Related]
30. Interaction of carbamazepine and phenobarbital in rabbits. Rukhadze MD, Alexishvili MM, Okujava NV, Sebiskveradze MV, Okujava VM, Tsagareli SK. Biomed Chromatogr; 2000 Aug; 14(5):344-8. PubMed ID: 10960836 [Abstract] [Full Text] [Related]
31. Population pharmacokinetic modelling of carbamazepine in epileptic elderly patients: implications for dosage. Bondareva IB, Jelliffe RW, Gusev EI, Guekht AB, Melikyan EG, Belousov YB. J Clin Pharm Ther; 2006 Jun; 31(3):211-21. PubMed ID: 16789986 [Abstract] [Full Text] [Related]
32. Modulation of CYP3A enzyme activity by diosmin and its consequence on carbamazepine pharmacokinetics in rats. Bedada SK, Neerati P. Naunyn Schmiedebergs Arch Pharmacol; 2018 Feb; 391(2):115-121. PubMed ID: 29134244 [Abstract] [Full Text] [Related]
33. 1-Methyl-1,2,3,4-tetrahydroisoquinoline enhances the anticonvulsant action of carbamazepine and valproate in the mouse maximal electroshock seizure model. Luszczki JJ, Antkiewicz-Michaluk L, Czuczwar SJ. Neuropharmacology; 2006 Feb; 50(2):133-42. PubMed ID: 16153667 [Abstract] [Full Text] [Related]
34. Interaction of carbamazepine and chlorpromazine in rabbits. Rukhadze MD, Alexishvili MM, Okujava VM, Makharadze TG, Sebiskveradze MV, Tsagareli SK. Biomed Chromatogr; 1999 Nov; 13(7):445-9. PubMed ID: 10534754 [Abstract] [Full Text] [Related]
35. Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects. Conte JE, Golden JA, McIver M, Zurlinden E. Int J Antimicrob Agents; 2006 Aug; 28(2):114-21. PubMed ID: 16837169 [Abstract] [Full Text] [Related]
36. Pharmacokinetic interaction between efavirenz and carbamazepine after multiple-dose administration in healthy subjects. Ji P, Damle B, Xie J, Unger SE, Grasela DM, Kaul S. J Clin Pharmacol; 2008 Aug; 48(8):948-56. PubMed ID: 18519918 [Abstract] [Full Text] [Related]
37. [Pharmacokinetics of fudosteine in healthy volunteers]. Ding L, Yang J, Li RS, Zhou M, Shen JP, Zhang YD. Yao Xue Xue Bao; 2005 Oct; 40(10):945-9. PubMed ID: 16408815 [Abstract] [Full Text] [Related]
38. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers. Kapil R, Nolting A, Roy P, Fiske W, Benedek I, Abramowitz W. Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765 [Abstract] [Full Text] [Related]
39. Lepidium sativum but not Nigella sativa affects carbamazepine disposition in an animal model. Alkharfy KM, Al-Jenoobi FI, Alam MA, Al-Mohizea AM, Al-Suwayeh SA, Korashy HM, Khan RM, Muzaffar I. Drug Metab Lett; 2013 Mar; 7(1):47-51. PubMed ID: 23952676 [Abstract] [Full Text] [Related]
40. Single dose pharmacokinetics of HEPP, a new anticonvulsant in normal healthy volunteers. González-Esquivel DF, Rubio-Donnadieu F, Carvajal-Sandoval G, Jung HC. Biopharm Drug Dispos; 1998 Dec; 19(9):583-7. PubMed ID: 9872340 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]